Neuralink
Overview
Sectors
Health, BioTech
Headquarters
Fremont, California, USA
CEO
Elon Musk
Neuralink raised $280.0M in a Series D Valuation at a $19.03 price per share, amounting to a post-money valuation of $5.0B on August 1, 2023. ApeVue data indicates that Neuralink's shares have been trading at an 142.0% premium to their Series D Valuation based on institutional secondary market activity.
Register today to view the full report, with more in-depth details and analytics
Series D Valuation
Latest funding round
$5.0B
XXXXX
2023-08-01
XX-XX-XXXX
AV Implied Valuation
$12.1B
2024-12-30
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
+142.0%
2023-08-01 ➞ 2024-12-30
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
Medium
XXXXX
Volume
$133.86M
XXX
Research
News
Ready to see it in action?
Schedule a demo with one of our experts